Highlights genOway

Equities

ALGEN

FR0004053510

Real-time Euronext Paris Other stock markets 03:27:45 2024-06-27 EDT			5-day change	1st Jan Change
4.03 ^EUR	0.00%		-1.71%	-12.39%

2023	GenOway: sharp rise, broker initiates buy recommendation	CF
2023	GENOWAY : Euroland initiates buy coverage	CF

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

GenOway: profitability target achieved ahead of schedule	23-09-22	CF
GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-19	CI
Sigma-Aldrich and genOway Expand Their CRISPR/CAS9 Strategic Alliance	22-09-08	CI
GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
GenOway Grants the Leading UK Academic Research Funder A Non-Exclusive License for CRISPR/Cas9 Technology	22-01-25	CI
Global markets live: Michelin, Facebook, UBS, Tesla, Volvo...	21-10-26
Genoway Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-27	CI
Genoway Soci?T? Anonyme Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Genoway S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-17	CI
GenOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Partnership to All Animal Cell Models	20-01-07	CI
Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models	18-12-10	CI
GenOway S.A. acquired AXENIS S.A.S from Institut Pasteur de Lille.	18-09-24	CI
GenOway Société Anonyme agreed to acquire AXENIS S.A.S from Institut Pasteur de Lille for €0.19 million.	18-09-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer